GAS5 lncRNA: A biomarker and therapeutic target in breast cancer
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Growth Arrest-Specific 5 (Gas5) long non-coding RNA plays a key role in breast cancer. Restoring Gas5 levels can suppress tumor growth and enhance treatment sensitivity, offering a potential therapeutic strategy.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- Breast cancer is a leading cause of cancer mortality, often characterized by aggressive phenotypes and poor treatment outcomes.
- Growth Arrest-Specific 5 (Gas5) long non-coding RNA (lncRNA) is implicated in regulating apoptosis and tumor aggressiveness in breast cancer.
- Dysregulation of Gas5 levels is associated with increased invasion, metastasis, and reduced sensitivity to chemotherapy.
Purpose Of The Study
- To review the significant role of Gas5 in modulating apoptosis and tumor aggressiveness in breast cancer.
- To highlight the potential of Gas5 as a therapeutic target for breast cancer treatment and management.
- To emphasize Gas5's potential as a diagnostic and predictive biomarker.
Main Methods
- Literature review of studies investigating the function of Gas5 in breast cancer.
- Analysis of Gas5's regulatory mechanisms on apoptotic proteins (caspases, BCL2 family).
- Examination of Gas5's influence on epithelial-mesenchymal transition (EMT) markers and signaling pathways.
Main Results
- Gas5 enhances apoptosis and chemo-sensitivity by regulating key apoptotic proteins.
- Low Gas5 levels correlate with increased tumor invasion, metastasis, and aggressiveness.
- Gas5 influences tumor cell proliferation and EMT, critical processes in cancer progression.
Conclusions
- Gas5 is a crucial modulator of apoptosis and tumor aggressiveness in breast cancer.
- Restoring Gas5 levels presents a promising therapeutic strategy to suppress tumor development.
- Gas5 activity levels may serve as a valuable indicator for breast cancer diagnosis and prognosis.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...